Komori
Showa Sangyo (2004) · FactFirst stated

R&D Expenses for FY2027-H1

First written in FY2027-H1. . Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Ongoing Disclosure of Research and Development ExpensesA theme 15 companies write about · 1 as a headwind · 5 as a tailwind

2 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 15 companies compared. The sentences above are computed from all 15.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1First statedAnnual report

    「The Group's total research and development expenditure for the current interim consolidated accounting period was ¥1,376 million.」

    The Group disclosed research and development expenditure of ¥1,376 million for FY2027-H1.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Showa Sangyo yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
R&D Expenses for FY2027-H1 | Showa Sangyo Co.,Ltd. (2004) | Komori